These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion]. Heidrich H; Wehselau H Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152 [No Abstract] [Full Text] [Related]
3. [Value of vasodilator agents in neuropsychiatric practice and study of the indications for Praxilene]. Bornstein S; Sère de Rivières H Therapeutique; 1972 Jan; 48(1):27-34. PubMed ID: 5046366 [No Abstract] [Full Text] [Related]
9. [Naftidrofuryl, a new blood vessel-active substance in the preparation for arterial vascular surgery]. Becker HM Med Klin; 1970 Feb; 65(8):359-61. PubMed ID: 5519232 [No Abstract] [Full Text] [Related]
10. Modern trends in the therapy of venous affections of the lower limbs. Borri P; Taborelli R Panminerva Med; 1966 Oct; 8(10):373-7. PubMed ID: 4166939 [No Abstract] [Full Text] [Related]
11. [Comparison between xenon 133 and thermography in experimental study of a vasodilator agent]. Beurey J; Weber M; Saussure M; Bertrand A; Robert J Bull Soc Fr Dermatol Syphiligr; 1972; 79(1):68-70. PubMed ID: 4565812 [No Abstract] [Full Text] [Related]
12. [Treatment of primary and secondary Raynaud's syndrome using naftidrofuryl (Dusodril)]. Kriessmann A; Sauer E Dtsch Med J; 1971 Dec; 22(23):743-5. PubMed ID: 5135008 [No Abstract] [Full Text] [Related]
13. [Treatment of functional changes in arteriosclerotic chronic obliterating peripheral arterial diseases (COPA) and Buerger's and Raynaud's diseases with pharmacological sympathicolysis, with or without indirect surgical treatment]. Bagliani A; Borri P; Taborelli R Minerva Cardioangiol; 1973 Jun; 21(6):439-52. PubMed ID: 4720185 [No Abstract] [Full Text] [Related]
14. [Therapeutic results in peripheral and cerebrovascular blood circulation disorders following the administration of Dusodril]. Kaufmann J; Förster W Z Allgemeinmed; 1970 May; 46(13):688-9. PubMed ID: 5522940 [No Abstract] [Full Text] [Related]
16. [Effects of naftidrofuryl on the cerebral blood flow]. Péchadre JC; Simard D Rev Neurol (Paris); 1974; 130(7-8):301-7. PubMed ID: 4453760 [No Abstract] [Full Text] [Related]
17. [Possibilities of the use of isoxsuprine even in topical administration in the treatment of chronic ulcerative lesions of the legs]. Santini R; Franchi A Minerva Cardioangiol; 1975 Jan; 23(1):33-42. PubMed ID: 1143646 [No Abstract] [Full Text] [Related]
18. [A new possibility of drug treatment of leg diseases]. Brunner N Z Haut Geschlechtskr; 1970 Jan; 45(2):85-90. PubMed ID: 5420448 [No Abstract] [Full Text] [Related]
19. [Study of the general tolerance of Naftidrofuryl in daily intra-arterial perfusions]. Tingaud R; Massé C; Faure L; Fischer Bord Med; 1970 Nov; 3(11):2797-801 passim. PubMed ID: 5510152 [No Abstract] [Full Text] [Related]
20. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl]. Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084 [No Abstract] [Full Text] [Related] [Next] [New Search]